Navigation Links
Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results

further clinical study results to potentially establish Inovio's DNA delivery technology as the delivery method of choice for localized administration of DNA treatments."

Enrollment of this study has been completed and further results are expected in the second half of 2007.

About Inovio's Immunotherapy Products

DNA-based immunotherapy products have the potential to by-pass inherent scientific obstacles of conventional vaccines that prevent their development for cancer and chronic infectious diseases such as HIV and hepatitis C. Pre-clinical data has indicated the potential ability of Inovio's technologies to safely and effectively deliver and significantly enhance the potency of such immunotherapies.

Inovio's DNA-based immunotherapy products consist of DNA plasmids and the Elgen and MedPulser DNA delivery systems. DNA plasmids are designed to express antigens that can induce an immune response specific to a cancer or infectious disease-causing organism. These plasmids are created synthetically and readily manufactured using well-established bacterial fermentation and purification technology. After a plasmid is delivered into muscle or tumor cells, production of the desired antigens may then induce a preventive or therapeutic immune response against the targeted disease. Inovio's advanced electroporation devices facilitate delivery and expression of such immunotherapies and have been shown in primate studies to boost antibody and T-cell immune response by orders of magnitude over DNA plasmid alone, suggesting the potential to provide better protection from complex infectious diseases such as HIV and hepatitis C as well as cancers such as prostate and breast cancers.

Inovio is poised to deliver advanced DNA-based immunotherapies, devices and know-how in this rapidly advancing field. The company is actively licensing its technology to pharmaceutical and biotechnology companies and supporting early stage clinical studies arising from
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
2. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
3. Inovio: DNA delivery technology shows positive human results
4. Inovio Biomedicals Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
5. Inovio Biomedicals DNA Delivery Technology Significantly Enhances Potency of HIV DNA Vaccine
6. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
10. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
11. News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
Post Your Comments:
(Date:2/26/2015)... The report, "Bottled Water ... Capper, Blow molder, Shrink wrapper), Technology (RO, UF, ... & Region - Trends & Forecasts to 2019", ... water processing market with analyses and projection of ... It also identifies the driving and restraining factors ...
(Date:2/26/2015)... PORTLAND, Ore. , Feb. 26, 2015 /PRNewswire-USNewswire/ ... providers will have the opportunity to participate in ... outcomes when the first independent U.S. psoriasis registry ... registry, a joint collaboration with the National Psoriasis ... drug safety reporting for secukinumab, a new biologic ...
(Date:2/26/2015)...  MEI Pharma, Inc. (Nasdaq: MEIP ), an ... for cancer, announced today that Daniel P. Gold , ... Cowen and Company 35 th Annual Health Care Conference ... from the Boston Marriott Copley Place. A live webcast of ... replay will be available approximately one hour after the presentation. ...
Breaking Medicine Technology:Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4First independent U.S. psoriasis registry will track drug safety and effectiveness 2First independent U.S. psoriasis registry will track drug safety and effectiveness 3MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3
... 21 Actavis Group, the international generic pharmaceuticals company, today ... Drug Administration to market Bupropion HCl Extended-Release (SR) tablets 100mg and ... , , ... the generic equivalent of Wellbutrin® SR by GlaxoSmithKline, are now available ...
... STAMFORD, Conn. , July 21 Zargis ... SPDE ), today announced that it received a contract from ... the success of the Signal-X6™ telemedicine systems recently deployed to ... the new contract, Zargis will develop prototype versions of the ...
Cached Medicine Technology:Actavis Receives Approval of Bupropion HCl SR 100mg and 200mg in the U.S. 2Zargis Awarded U.S. Army Contract 2Zargis Awarded U.S. Army Contract 3
(Date:2/26/2015)... 2015 Catalent Pharma Solutions, ... technologies and development solutions for drugs, biologics ... several expanded capabilities within its European Clinical ... implemented in response to increased customer demand ... of highly-potent or temperature-sensitive investigational medical products ...
(Date:2/26/2015)... 26, 2015 Participants in the ... Working? What’s Not? What’s New? ,” will learn ... to achieve strong outcomes for duals-plan members and ... in the implementation phase of programs for Medicare-Medicaid ... Which ones need to be implemented in the ...
(Date:2/26/2015)... NJ (PRWEB) February 26, 2015 The ... reopening of their newly renovated office in Lawrenceville, NJ. ... Reproductive Science Center of New Jersey’s physicians, and NJ ... and patient care in the areas of infertility and ... for having excellent success rates and providing current, high ...
(Date:2/26/2015)... 26, 2015 Software and Cybersecurity ... Position and Best Practices for Compliance, **Presented by ... MD, http://www.fdanews.com/SoftwareAndCybersecurity , This workshop — ... has been specifically designed to provide attendees with ... assure medical device software safety. , In fact, ...
(Date:2/26/2015)... Michigan (PRWEB) February 26, 2015 A ... procedures that accomplish two different things—but they can be ... blending a tummy tuck with liposuction, Michigan’s Dr. Pramit ... which he's seen grow in popularity by 50 percent ... Why are more patients seeking to combine the two? ...
Breaking Medicine News(10 mins):Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 2Health News:Catalent Expands European Clinical Packaging Capabilities, Highlighting Growing Industry Need for Specialty Handling 3Health News:Upcoming AIS Virtual Conference Will Explain What Is and Is Not Working in Medicare-Medicaid Dual Eligibles Programs 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 2Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 3Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 4Health News:Dr. Pramit Malhotra Reports a Rise in Patients Combining Liposuction and Tummy Tuck in Michigan, Citing the “Power LipoTuck” 2Health News:Dr. Pramit Malhotra Reports a Rise in Patients Combining Liposuction and Tummy Tuck in Michigan, Citing the “Power LipoTuck” 3
... more than 33,000 Americans per year, experts say , , ... they,ve spotted several potential new drug targets for the ... by a bacterial infection that enters the bloodstream, is ... tens of thousands of Americans a year. , In ...
... of Minnesota School of Public Health and the University ... programs prior to sixth grade, when nearly one in ... that adolescents who already use alcohol are less receptive ... earlier ages, specifically between third and fifth grade, would ...
... Riverview Medical,Center, located in Red Bank, ... the J.D. Power and Associates Distinguished Hospital,Program(SM). ... Riverview,Medical Center to provide an "outstanding emergency ... The service excellence distinction was determined ...
... and supplement manufacturers are often at odds, they,don,t ... half the,physicians on the Harvard Men,s Health Watch ... years, Harvard Men,s Health Watch has,also endorsed these ... they won,t hurt. However, the March 2008 issue ...
... The Association for Professionals in Infection Control and ... selected by Blue Shield of California Foundation (BSCF) ... healthcare-associated infections (HAIs). , APIC will join BSCF ... Foundations innovative California Healthcare-Associated Infection Prevention Initiative to ...
... the ,I ... in the Kitchen(TM), Campaign, NEW YORK, Feb. 27 /PRNewswire-FirstCall/-- ... involves using 70 percent,store-bought items and 30 percent homemade items ... Unknown to most, Lee,s signature,style was strongly influenced by her ...
Cached Medicine News:Health News:Research May Yield New Weapons Against Sepsis 2Health News:U of Minn researchers find primary alcohol prevention programs are needed for 'tweens' 2Health News:J.D. Power and Associates Reports: Riverview Medical Center Recognized for Providing an Emergency Department Experience 2Health News:J.D. Power and Associates Reports: Riverview Medical Center Recognized for Providing an Emergency Department Experience 3Health News:It's Time to Reassess the Value, Safety of Multivitamin Use, Says Harvard Men's Health Watch 2Health News:Celebrity Chef Sandra Lee Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis 2Health News:Celebrity Chef Sandra Lee Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis 3Health News:Celebrity Chef Sandra Lee Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis 4Health News:Celebrity Chef Sandra Lee Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis 5Health News:Celebrity Chef Sandra Lee Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: